Weight | 1 lbs |
---|---|
Dimensions | 9 × 5 × 2 in |
host | rabbit |
isotype | IgG |
clonality | polyclonal |
concentration | 1 mg/mL |
applications | IHC, WB |
reactivity | polyclonal, rabbit, Superoxide Dismutase 1 (SOD) |
available sizes | 1 mg, 100 µg, 25 µg |
rabbit anti-SOD1 polyclonal antibody 1001
$100.00 – $2,600.00
Antibody summary
- Rabbit polyclonal to Superoxide Dismutase 1 (SOD)
- Suitable for: WB,IHC
- Reacts with: Hu
- Isotype: IgG
- 100 µg, 25 µg, 1 mg
rabbit anti- sod1 polyclonal antibody 1001
antibody |
---|
Database link: human P00441 mouse P08228 rat P07632 |
Tested applications WB,IHC |
Recommended dilutions WB: 1:2000-10000, IHC: 1:2000-10000, Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. |
Immunogen The epitope recognized by A303-811A maps to a region between residue 54 and 104 of human Superoxide Dismutase 1 using the numbering given in entry NP_000445.1 (GeneID 6647). |
Size and concentration 100µL and 1 mg/mL |
Form liquid |
Storage Instructions 2-8°C for short term, for longer term at -20°C. Avoid freeze / thaw cycles. |
Storage buffer Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09% Sodium Azide |
Purity affinity purified |
Clonality polyclonal |
Isotype IgG |
Compatible secondaries goat anti-rabbit IgG, H&L chain specific, peroxidase conjugated, conjugated polyclonal antibody 9512 goat anti-rabbit IgG, H&L chain specific, biotin conjugated polyclonal antibody 2079 goat anti-rabbit IgG, H&L chain specific, FITC conjugated polyclonal antibody 7863 goat anti-rabbit IgG, H&L chain specific, Cross Absorbed polyclonal antibody 2371 goat anti-rabbit IgG, H&L chain specific, biotin conjugated polyclonal antibody, crossabsorbed 1715 goat anti-rabbit IgG, H&L chain specific, FITC conjugated polyclonal antibody, crossabsorbed 1720 |
Isotype control Rabbit polyclonal - Isotype Control |
target relevance |
---|
Protein names Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) (Superoxide dismutase 1) (hSod1) |
Gene names SOD1,SOD1 |
Protein family Cu-Zn superoxide dismutase family |
Mass 15936Da |
Function FUNCTION: Destroys radicals which are normally produced within the cells and which are toxic to biological systems. {ECO:0000269|PubMed:24140062}. |
Catalytic activity CATALYTIC ACTIVITY: Reaction=2 H(+) + 2 superoxide = H2O2 + O2; Xref=Rhea:RHEA:20696, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:18421; EC=1.15.1.1; Evidence={ECO:0000269|PubMed:24140062}; |
Subellular location SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19741096}. Nucleus {ECO:0000269|PubMed:22496122}. Note=Predominantly cytoplasmic; the pathogenic variants ALS1 Arg-86 and Ala-94 gradually aggregates and accumulates in mitochondria. {ECO:0000269|PubMed:19741096}. |
Structure SUBUNIT: Homodimer; non-disulfide-linked (By similarity). Homodimerization may take place via the ditryptophan cross-link at Trp-33. Heterodimer with SOD1 (PubMed:31292775). The heterodimer CCS:SOD1 interacts with SLC31A1; this heterotrimer is Cu(1+)-mediated and its maintenance is regulated through SOD1 activation (PubMed:31292775). Interacts with DAOA; the interaction is direct (PubMed:30037290). {ECO:0000250|UniProtKB:P08228, ECO:0000269|PubMed:10329151, ECO:0000269|PubMed:12911296, ECO:0000269|PubMed:12963370, ECO:0000269|PubMed:15326189, ECO:0000269|PubMed:16291742, ECO:0000269|PubMed:16406071, ECO:0000269|PubMed:17548825, ECO:0000269|PubMed:17888947, ECO:0000269|PubMed:20600836, ECO:0000269|PubMed:20727846, ECO:0000269|PubMed:30037290, ECO:0000269|PubMed:31292775}. |
Post-translational modification PTM: Unlike wild-type protein, the pathogenic variants ALS1 Arg-38, Arg-47, Arg-86 and Ala-94 are polyubiquitinated by RNF19A leading to their proteasomal degradation. The pathogenic variants ALS1 Arg-86 and Ala-94 are ubiquitinated by MARCH5 leading to their proteasomal degradation. {ECO:0000269|PubMed:12145308, ECO:0000269|PubMed:19741096}.; PTM: The ditryptophan cross-link at Trp-33 is responsible for the non-disulfide-linked homodimerization. Such modification might only occur in extreme conditions and additional experimental evidence is required. {ECO:0000269|PubMed:20600836}.; PTM: Palmitoylation helps nuclear targeting and decreases catalytic activity. {ECO:0000269|PubMed:22496122}.; PTM: Succinylation, adjacent to copper catalytic site, probably inhibits activity. Desuccinylation by SIRT5 enhances activity. {ECO:0000269|PubMed:24140062}. |
Target Relevance information above includes information from UniProt accession : P00441 |
The UniProt Consortium |
Data
Publications
Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.pmid | title | authors | citation |
---|
Protocols
relevant to this product |
---|
Western blot IHC |
Documents
# | |||
---|---|---|---|
No results found |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.